The Finnish Medix Biochemica company is a pioneer in pregnancy diagnostics
Medix Biochemica is a Finnish biotechnology company that develops, produces and markets rapid diagnostic tests for healthcare professionals around the world.
The company’s rapid test business specialises in women’s health and, in particular, testing that examines pregnancy complications.
Actim tests provide groundbreaking healthcare solutions for testing pregnancy complications. The Actim PROM test, for example, has crucially improved the diagnostics of premature rupture of membranes. During the last 20 years, over seven million Actim tests have been used to ensure the safety of pregnant mothers and babies all around the world.
Medix Biochemica’s headquarters are located in Espoo and its tests are manufactured in its own factory in Joensuu. The company employs about 90 biotechnology professionals. The company, founded in 1985, is owned by the Minerva Foundation, a non-profit foundation focusing on medical research. The company’s revenues go to basic research. Medix Biochemica adheres to the highest possible international quality standards.